Real-time enrollment status for this primary hyperoxaluria clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 8:11 AM UTC
| NCT Number | NCT06839235 |
| Recruiting Status | Recruiting |
| Condition | Primary Hyperoxaluria |
| Phase | Clinical Trial |
| Target Enrollment | 23 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Arbor Biotechnologies |
| Last Updated on CT.gov | February 12, 2026 (Feb 12, 2026) |
As of April 17, 2026: Clinical trial NCT06839235 is currently recruiting participants. This clinical trial study for primary hyperoxaluria is actively seeking new participants at 2 locations across the United States. The study is sponsored by Arbor Biotechnologies. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06839235 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06839235 was last updated Feb 12, 2026 (February 12, 2026). HelloStudys verifies this status automatically.